Evidence map›Paper›PMID 42640782›Full record

ArticleCell reports2026

Mutant p53 gains RNA-binding activity to reprogram translation and mitochondrial function.

Wuyue Zhou, Alice Long, Cameron J Douglas, Dalila Gallegos, James M Burke, David W C MacMillan, Ezgi Hacisuleyman, Ciaran P Seath

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wuyue ZhouDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14850, USA; Department of Chemistry, Wertheim UF Scripps, Jupiter, FL 33458, USA; Skaggs Graduate School, The Scripps Research Institute, Jupiter, FL 33458, USA.
Alice LongDepartment of Chemistry, Princeton University, Princeton, NJ, USA.
Cameron J DouglasDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14850, USA; Department of Chemistry, Wertheim UF Scripps, Jupiter, FL 33458, USA; Skaggs Graduate School, The Scripps Research Institute, Jupiter, FL 33458, USA.
Dalila GallegosDepartment of Chemistry, Wertheim UF Scripps, Jupiter, FL 33458, USA.
James M BurkeSkaggs Graduate School, The Scripps Research Institute, Jupiter, FL 33458, USA; Department of Molecular Medicine, Wertheim UF Scripps, Jupiter, FL 33458, USA.
David W C MacMillanDepartment of Chemistry, Princeton University, Princeton, NJ, USA. Electronic address: dmacmill@princeton.edu.
Ezgi HacisuleymanSkaggs Graduate School, The Scripps Research Institute, Jupiter, FL 33458, USA; Department of Molecular Medicine, Wertheim UF Scripps, Jupiter, FL 33458, USA. Electronic address: f.hacisuleyman@ufl.edu.
Ciaran P SeathDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14850, USA; Department of Chemistry, Wertheim UF Scripps, Jupiter, FL 33458, USA; Skaggs Graduate School, The Scripps Research Institute, Jupiter, FL 33458, USA. Electronic address: cseath@cornell.edu.

Funding

Photoproximity labeling as a tool for epigenetic drug discoveryR35GM150765 · NIGMS · UNIVERSITY OF FLORIDA · PI Ciaran Seath · 2023 to 2026
$1.9M
Understanding the OAS/RNase L pathway during pathogenic viral infectionsR35GM151249 · NIGMS · UNIVERSITY OF FLORIDA · PI James M Burke · 2023 to 2026
$1.9M
Decoding RNA Localization and Local Translation: Key Mechanisms of Cellular Adaption and FunctionR35GM159898 · NIGMS · UNIVERSITY OF FLORIDA · PI Ezgi Hacisuleyman · 2025 to 2026
$932k
Vanquish Neo UHPLC for The Wertheim UF Scripps InstituteS10OD036363 · OD · UNIVERSITY OF FLORIDA · PI TSAPRAILIS, GEORGE · 2024 to 2024
$93k
NIGMS NIH HHS R35 GM150765NIGMS NIH HHS R35 GM151249NIGMS NIH HHS R35 GM159898NIH HHS S10 OD036363
6 · The paper itself

Abstract

Tumor suppressor p53 is a transcription factor mutated in ∼50% of cancers. Somatic mutations in the DNA-binding domain abolish tumor suppression and thus lead to a loss-of-function activity, while a small subset of recurrent "hotspot" mutants have been shown to confer gain-of-function activities. Using an intein-based μMap photoproximity labeling approach, we map the interactomes of five hotspot mutants and find that mutant p53 (mut p53) acquires interactions with RNA-binding proteins, shifts toward the cytoplasm, and shows increased proximity to structured RNA and RNA-binding proteins. CLIP (Cross-linking and immunoprecipitation) experiments show that mut p53 possesses an RNA-binding motif and is enriched at 3'UTRs, promoting ribosomal localization and localization at the mitochondrial surface. Using ribosome profiling, we further show that mut p53 alters translation and promotes changes in miRNA processing and mitochondrial function, providing a mechanistic rationale for historically reported but poorly understood phenotypes.

Indexed as

cancerCLIP-seqCP: cancerCP: molecular biologygain-of-functionmitochondriamutant p53proximity labelingribosome profilingRNA bindingtranslationμMap

Identifiers

PMID42640782
PMCPMC13559719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.